RE:RE:RE:RE:RE:RE:Questions about KNR for the current shareholderswilander wrote: I dont. Just the link and then the research note on my other post.
Np, thought you might have access to the analyst's report.
What are your thoughts about the relatively flat revenues in the past 8 quarters? Did Covid limit their growth (outside Biocloud) last year?
If I invest in KNR and expect a 25-30% growth in top line revenue, is that something reasonable? Think they can get $20M in revenue for 2021?
I know they target $100M in their presentation in 5 years, but can't see that happening without a lot of dilution and acquisitions going forward.